Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Meet Siggy, the AI mental health startup taking on psychiatry's biggest problem. Launching from stealth with $6 million in pre-seed funding, Siggy combines AI-driven intake, therapy support, and prescription management into one continuous care platform. It's accepted by major insurers in all 50 states — and it's free for veterans.
Meet Siggy, the AI mental health startup taking on psychiatry's biggest problem.
Siggy has emerged from stealth with $6 million in pre-seed funding, aiming to fix what its founders call a "fragmented" mental health system where therapists and prescribers rarely talk to each other. The platform combines AI-powered intake, therapy support, and prescription management into a single continuous care experience. Patients start with a free, anonymous AI conversation — no account required — and only pay if they accept treatment. A clinician reviews the AI's preliminary diagnosis before presenting treatment options.
Between monthly visits with a human provider, patients can engage with Siggy's AI agent, which tracks mood, sleep, medication side effects, and wearable data to generate a daily "Siggy Score" out of 100. When patterns shift, the system flags clinicians automatically. Siggy can prescribe non-controlled medications and is accepted by Blue Cross Blue Shield, Aetna, UnitedHealthcare, Humana, Medicaid, Medicare, and TRICARE.
By the Numbers:
Why it matters: With mental health care demand far outpacing supply, Siggy's model of persistent AI support layered with human oversight could help close the gap — particularly for patients who fall through the cracks of today's disconnected care system.
